Carlo Gambacorti-Passerini
- January 10, 2024
- Oncologist
Quick Facts
| Full Name | Carlo Gambacorti-Passerini |
| Occupation | Oncologist |
| Date Of Birth | Aug 26, 1957(1957-08-26) |
| Age | 67 |
| Birthplace | Milan |
| Country | Italy |
| Birth City | Lombardy |
| Horoscope | Leo |
Carlo Gambacorti-Passerini Biography
| Name | Carlo Gambacorti-Passerini |
| Birthday | Aug 26 |
| Birth Year | 1957 |
| Place Of Birth | Milan |
| Home Town | Lombardy |
| Birth Country | Italy |
| Birth Sign | Leo |
Carlo Gambacorti-Passerini is one of the most popular and richest Oncologist who was born on August 26, 1957 in Milan, Lombardy, Italy. Carlo Gambacorti – Passerini, an Italian oncologist/hematologist who was born 26 August 1957, is well-known for his contributions in cancer research. He is the Professor of Internal Medicine at the University of Milan Bicocca, Italy, and the Director of the Hematology Department of S. Gerardo Hospital in Monza, Italy. From 1990 to 2003, he was the Senior Investigator and Head at the National Cancer Institute in Milan, Italy. He also served as Professor of Oncology at McGill University in Montreal, Quebec, Canada from 2004 to 2007.
Dr. Gambacorti Passerini discovered ETNK1 and SETBP1 in 2012 and 2015. He also identified specific mutations in these genes in patients with atypical chronic myeloid leukemia (aCML)
He is also the first researcher to successfully treat ALK+ lymphoma patients with crizotinib (ALK inhibitor) in June 2010.
Carlo Gambacorti-Passerini Net Worth
| Net Worth | $5 Million |
| Source Of Income | Oncologist |
| House | Living in own house. |
Carlo Gambacorti-Passerini is one of the richest Oncologist from Italy. According to our analysis, Wikipedia, Forbes & Business Insider, Carlo Gambacorti-Passerini 's net worth $5 Million. (Last Update: December 11, 2023)
His major scientific contribution is to the clinical and preclinical development of imatinib. His publications from 1997 to 2000 were among the first original reports about this drug. He showed that imatinib’s primary mechanism of eliminating leukemic cells is apoptosis. This was a major reason that imatinib can be used to cure leukemia. Gene amplification of BCR–ABL could also be used to increase resistance.
Dr. Gambacorti Passerini is the chairman of the ILTE study (Imatinib Long Term side effects), an independent clinical study that assessed the long-term effects on CML patients. It was the first time that CML patients who are in remission had a normal life expectancy. From 2006 to 2011, Dr. Gambacorti Passerini was the first to develop a drug for CML called bosutinib at both preclinical and clinical levels.
Height, Weight & Body Measurements
Carlo Gambacorti-Passerini height Not available right now. Carlo weight Not Known & body measurements will update soon.
Who is Carlo Gambacorti-Passerini Dating?
According to our records, Carlo Gambacorti-Passerini is possibily single & has not been previously engaged. As of December 1, 2023, Carlo Gambacorti-Passerini’s is not dating anyone.
Relationships Record : We have no records of past relationships for Carlo Gambacorti-Passerini. You may help us to build the dating records for Carlo Gambacorti-Passerini!
Facts & Trivia
Carlo Ranked on the list of most popular Oncologist. Also ranked in the elit list of famous people born in Italy. Carlo Gambacorti-Passerini celebrates birthday on August 26 of every year.